The BioInsights Podcast
BioInsights
The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.
Episodes
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturingNovember 09, 2022
CAR-T cells: from cancer to autoimmunityOctober 12, 2022
Tales, tips & teachable moments from applications support veteransOctober 11, 2022
Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?September 30, 2022
De-risk & accelerate the drug development process for gene therapySeptember 29, 2022
Working Together to Safely Advance Cell & Gene TherapiesSeptember 27, 2022
Learning from pediatric CAR-T development: insights from manufacturing unique patient dosesSeptember 26, 2022
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take usSeptember 12, 2022
Making the switch from autologous to allogeneic cell therapySeptember 09, 2022
Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy spaceSeptember 05, 2022
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take usAugust 16, 2022
Achieving better AAV vector productivity and product qualityAugust 05, 2022
Partnering in life sciences: what is the ‘secret sauce’ for success? PART 2 July 25, 2022
Partnering in life sciences: what is the secret sauce for success? PART 1: The Big Pharma perspectiveJuly 18, 2022
Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?June 20, 2022
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?June 20, 2022
Where will tomorrow’s workforce come from? PART 2: How is the educational system responding, and how can the cell and gene therapy community at large help?June 07, 2022
Where will tomorrow’s workforce come from? PART1: Framing the issueJune 07, 2022
The quest for the Holy Grail in AAV chromatography: empty–full separationMay 25, 2022
Residual DNA testing in viral vector manufacture: exploring the challenges and solutionsMay 19, 2022
Precisely for CGT: automating aseptic filling for lowest volumesMay 10, 2022
CAR-T cells: from cancer to autoimmunityOctober 12, 2022
Tales, tips & teachable moments from applications support veteransOctober 11, 2022
Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?September 30, 2022
De-risk & accelerate the drug development process for gene therapySeptember 29, 2022
Working Together to Safely Advance Cell & Gene TherapiesSeptember 27, 2022
Learning from pediatric CAR-T development: insights from manufacturing unique patient dosesSeptember 26, 2022
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take usSeptember 12, 2022
Making the switch from autologous to allogeneic cell therapySeptember 09, 2022
Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy spaceSeptember 05, 2022
Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take usAugust 16, 2022
Achieving better AAV vector productivity and product qualityAugust 05, 2022
Partnering in life sciences: what is the ‘secret sauce’ for success? PART 2 July 25, 2022
Partnering in life sciences: what is the secret sauce for success? PART 1: The Big Pharma perspectiveJuly 18, 2022
Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?June 20, 2022
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?June 20, 2022
Where will tomorrow’s workforce come from? PART 2: How is the educational system responding, and how can the cell and gene therapy community at large help?June 07, 2022
Where will tomorrow’s workforce come from? PART1: Framing the issueJune 07, 2022
The quest for the Holy Grail in AAV chromatography: empty–full separationMay 25, 2022
Residual DNA testing in viral vector manufacture: exploring the challenges and solutionsMay 19, 2022
Precisely for CGT: automating aseptic filling for lowest volumesMay 10, 2022